Hunting for clues: study seeks to predict myeloma before it starts
NCT ID NCT02726750
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study follows 200 people with early blood conditions (MGUS or smoldering myeloma) that sometimes turn into multiple myeloma. Researchers will track age, blood protein levels, bone marrow cells, genes, and bone health to find patterns that predict progression. No treatments are tested; the goal is to improve future risk assessment and care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene clues may unlock new treatments for bone marrow cancer
- New blood test screening targets hidden cancer in black communities
- Gut bacteria drug shows promise against blood disorder
- Turmeric and black pepper extract shows promise in slowing early cancers
- 1,000 volunteers help scientists unlock the mystery of myeloma progression
- New italian network aims to catch rare blood disease earlier